Another pro-tumorigenic role for TRAIL was demonstrated in a TRAIL-resistant syngeneic murine orthotopic pancreatic cancer model where tumors grew faster, and survival was worse in wild-type mice compared to TRAIL null mice [250]. The gene discussed is TNFSF10; the disease is familial pancreatic carcinoma.